Unveiling the mechanism of recurrence and chemoresistance in neuroblastoma using genomewide and epigenomewide analysis
Project/Area Number |
26462721
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Pediatric surgery
|
Research Institution | National Center for Child Health and Development (2016) Chiba Cancer Center (Research Institute) (2014-2015) |
Principal Investigator |
Hishiki Tomoro 国立研究開発法人国立成育医療研究センター, 小児がんセンター, 医長 (00375776)
|
Co-Investigator(Kenkyū-buntansha) |
上條 岳彦 埼玉県立がんセンター(臨床腫瘍研究所), 臨床腫瘍研究所, 研究所長 (90262708)
吉田 英生 千葉大学, 大学院医学研究院, 教授 (60210712)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 神経芽腫 / 再発 / 網羅的ゲノム解析 / 全エクソーム解析 / エクソーム解析 / 網羅的エピゲノム解析 |
Outline of Final Research Achievements |
The prognosis of patients with high-risk neuroblastoma is extremely poor with a 5-year survival of 40%. Approximately 70% respond to chemotherapy but half of these patients experience recurrence. Once the tumor relapses, it gains chemoresistance and the outcome of relapsed patients is dismal. We hypothesized that tumors at diagnosis and recurrent tumors have different biological features based on different genomic and epigenetic rearrangements. We thus conducted a whole exome sequence for the tumors at diagnosis and tumors at recurrence in the identical patient. In one case, we found a novel somatic mutation in the recurrent tumor in a molecule that is not involved in the Ras-MAP kinase cascade, in which molecules has previously shown to be frequently mutated in recurrent tumors. This finding suggests that a somatic mutation in a molecule distinct from the Ras-MAPK cascade could also trigger relapse and chemoresistance in neuroblastoma.
|
Report
(4 results)
Research Products
(30 results)
-
[Journal Article] Genomic Analysis-Integrated Whole-exome Sequencing of Neuroblastomas Identifies Genetic Mutations in Axon Guidance Pathway.2017
Author(s)
Yuanyuan Li, Miki Ohira, Yong Zhou, Teng Xiong, Wen Luo, Chao Yang, Xiangchun Li, Zhibo Gao, Yohko Nakamura, Takehiko Kamijo, Yasuhiko Kaneko, Takeshi Taketani, Junichi Ueyama, Tatsuro Tajiri, Hongyan Zhang, Jian Wang, Huanming Yang, Ye Yin, and Akira Nakagawara.
-
Journal Title
ONCOTARGET
Volume: in press
Related Report
Peer Reviewed / Int'l Joint Research
-
[Journal Article] Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration.2017
Author(s)
Meyers RL, Maibach R, Hiyama E, Harberle B, Krailo M, Rangaswami A, Aronson DC, Malogolowkin MH, Perilongo G, von Schweinitz D, Ansari M, Lopez-Terrada D, Tanaka Y, Alaggio R, Leuschner I, Hishiki T, Schmid I, Watanabe K, Yoshimura K, Feng Y, Rinaldi E, Saraceno D, Derosa M, Czauderna P.
-
Journal Title
Lancet Oncol.
Volume: 18
Issue: 1
Pages: 122-131
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates2016
Author(s)
Honda S, Minato M, Suzuki H, Fujiyoshi M, Miyagi H, Haruta M, Kaneko Y, Hatanaka KC, Hiyama E, Kamijo T, Okada T, Taketomi A
-
Journal Title
Cancer Science
Volume: in press
Issue: 6
Pages: 812-819
DOI
NAID
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.2016
Author(s)
Hiyama E, Hishiki T, Watanabe K, Ida K, Yano M, Oue T, Iehara T, Hoshino K, Koh K, Tanaka Y, Kurihara S, Ueda Y, Onitake Y.
-
Journal Title
J Pediatr Surg.
Volume: 51
Issue: 12
Pages: 2053-2057
DOI
Related Report
Peer Reviewed
-
[Journal Article] Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells.2016
Author(s)
Mise N, Takami M, Suzuki A, Kamata T, Harada K, Hishiki T, Saito T, Terui K, Mitsunaga T, Nakata M, Ikeuchi T, Nakayama T, Yoshida H, Motohashi S
-
Journal Title
Cancer Science
Volume: 107
Issue: 3
Pages: 233-241
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] The Children's Hepatic tumors International Collaboration (CHIC): Novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model2015
Author(s)
Czauderna P, Haeberle B, Hiyama E, Rangaswami A, Krailo M, Maibach R, Rinaldi E, Feng Y, Aronson D, Malogolowkin M, Yoshimura K, Leuschner I, Lopez-Terrada D, Hishiki T, Perilongo G, von Schweinitz D, Schmid I, Watanabe K, Derosa M, Meyers R
-
Journal Title
European Journal of Cancer
Volume: 1
Pages: 92-101
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
-
[Journal Article] Prognostic significance of Aminopeptidase-N (CD13) in hepatoblastoma2015
Author(s)
Saida S, Watanabe KI, Kato I, Fujino H, Umeda K, Okamoto S, Uemoto S, Hishiki T, Yoshida H, Tanaka S, Adachi S, Niwa A, Nakahata T, Heike T
-
Journal Title
Pediatrics International
Volume: in press
Issue: 4
Pages: 558-566
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers: potential biomarker implications.2014
Author(s)
Sun, Y., Furihata, T., Ishii, S., Nagai, M., Harada, M., Shimozato, O., Kamijo, T., Motohashi, S., Yoshino, I., Kamiichi, A., Kobayashi, K. and Chiba, K.
-
Journal Title
Clin. Transl. Med.
Volume: 3
Issue: 1
Pages: 37-37
DOI
Related Report
Peer Reviewed / Open Access
-
-
[Journal Article] Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma2014
Author(s)
Hishiki T, Horie H, Higashimoto Y, Yotsumoto K, Komatsu S, Okimoto Y, Kakuda H, Taneyama Y, Saito T, Terui K, Mitsunaga T, Nakata M, Ochiai H, Hino M, Ando K, Yoshida H, Iwai J
-
Journal Title
Pediatric Surgery International
Volume: 30
Issue: 9
Pages: 919-926
DOI
Related Report
Peer Reviewed
-
-
[Presentation] 13.Trisomy 12 occurs before alteration of IGF2 expression and predicts favorable outcome in patients with Wilms tumors.2016
Author(s)
Kaneko Y, Haruta M, Kamijo T, Arai Y, Okita H, Tanaka T, Takimoto H, Nakadate H, Oue T, Nozaki M, M Chin, Koshinaga T, Fukuzawa M.
Organizer
48th Annual Congress of the International Society of Paediatric Oncology.
Place of Presentation
ダブリン
Year and Date
2016-10-19
Related Report
Int'l Joint Research
-
-
-
[Presentation] 4.神経芽腫幹細胞を制御する新規シグナル経路の解析2016
Author(s)
Miki Ohira, Koji Chikaraishi, Kyosuke Mukae, Nobuhiro Akita, Masayuki Haruta, Haruhiko Koseki, Takehiko Kamijo
Organizer
第75回日本癌学会学術総会
Place of Presentation
横浜
Year and Date
2016-10-06
Related Report
-
[Presentation] CDX1 regulates cancer stemness pathway in neuroblastoma, CDX1 regulates cancer stemness pathway in neuroblastoma2016
Author(s)
Hisanori Takenobu, Miki Ohira, Koji Chikaraishi, Nobuhiro Akita, Yohko Yamaguchi, Masayuki Haruta, Akira Nakagawara, Manabu Nakayama, Haruhiko Koseki, Takehiko Kamijo
Organizer
国際神経芽腫学会 (ANR2016)
Place of Presentation
ケアンズ, オーストラリア
Year and Date
2016-06-19
Related Report
Int'l Joint Research
-
[Presentation] Primary tumor resection after high dose chemotherapy with autologous hematopoietic stem cell transplantation is a safe and feasible option. A report from the Japanese neuroblastoma study group (JNBSG).2016
Author(s)
11.Hishiki T, Yoneda A, Kuroda T, Tokiwa K, Ise K, Ono S, Kinoshita Y, Uehara S, Matsumoto K, Kumagai M, Shichino H, Soejima T, Takimoto T, Hara J, Tajiri T, Nakagawara A.
Organizer
国際神経芽腫学会 (ANR2016)
Place of Presentation
ケアンズ, オーストラリア
Year and Date
2016-06-19
Related Report
Int'l Joint Research
-
-
[Presentation] 半定量的MIBGスコアによる転移性神経芽腫治療反応性の判定と初期反応不良例の臨床的生物学的特徴2014
Author(s)
Tomoro Hishiki, Yasuyuki Higashimoto, Katsumi Yotsumoto, Shugo Komatsu, Yuri Okimoto, Harumi Kakuda, Yuichi Taneyama, Kazuki Furudate, Takeshi Saito, Keita Terui, Tetsuya Mitsunaga, Mitsuyuki Nakata, Hidemasa Ochiai, Moeko Koshino, Kumiko Ando, Hideo Yoshida, and Jun Iwai
Organizer
第52回日本小児血液・がん学会学術集会
Place of Presentation
岡山市
Year and Date
2014-11-28 – 2014-11-30
Related Report
-
[Presentation] TUMOR HISTOLOGY FOLLOWING INDUCTION CHEMOTHERAPY AND / OR HIGH-DOSE CHEMOTHERAPY AND ITS IMPACT ON THE OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA2014
Author(s)
Tomoro Hishiki, Hiroshi Horie, Yasuyuki Higashimoto, Katsumi Yotsumoto, Shugo Komatsu, Yuri Okimoto, Harumi Kakuda, Yuichi Taneyama, Takeshi Saito, Keita Terui, Tetsuya Mitsunaga, Mitsuyuki Nakata, Hidemasa Ochiai, Moeko Hino, Kumiko Ando, Hideo Yoshida, and Jun Iwai
Organizer
46th annual congress of SIOP
Place of Presentation
トロント市(カナダ)
Year and Date
2014-10-22 – 2014-10-25
Related Report
-
-